COSOPT Preservative-Free 20 mg/ml + 5 mg/ml, eye drops, solution in single-dose container Malta - Ingliż - Malta Medicines Authority

cosopt preservative-free 20 mg/ml + 5 mg/ml, eye drops, solution in single-dose container

santen oy niittyhaankatu 20, 33720 tampere, finland - eye drops, solution - dorzolamide 20 mg/ml timolol 5 mg/ml - ophthalmologicals

Travic 40 micrograms/ml eye drops, solution in single-dose container Malta - Ingliż - Malta Medicines Authority

travic 40 micrograms/ml eye drops, solution in single-dose container

uni-pharma kleon tsetis pharmaceutical laboratories s.a. 14th km national road athens - lamia 1, gr-145 64 kifissia, greece - eye drops, solution - travoprost 40 µg/ml - ophthalmologicals

Travatan 0.004% Eye Drops New Zealand - Ingliż - Medsafe (Medicines Safety Authority)

travatan 0.004% eye drops

novartis new zealand ltd - travoprost 40 µg/ml;   - eye drops, solution - 40 mcg/ml - active: travoprost 40 µg/ml   excipient: benzalkonium chloride boric acid disodium edetate dihydrate hydrochloric acid mannitol polyethylene glycol hydrogenated castor oil purified water sodium hydroxide trometamol - travatan eye drops are indicated to decrease elevated intraocular pressure in: · ocular hypertension · open-angle glaucoma as monotherapy or as adjunctive therapy.

SIMBRINZA 1%/0.2% brinzolamide 1% and brimonidine tartrate 0.2% eye drops suspension bottle Awstralja - Ingliż - Department of Health (Therapeutic Goods Administration)

simbrinza 1%/0.2% brinzolamide 1% and brimonidine tartrate 0.2% eye drops suspension bottle

novartis pharmaceuticals australia pty ltd - brimonidine tartrate, quantity: 2 mg/ml; brinzolamide, quantity: 10 mg/ml - eye drops, suspension - excipient ingredients: propylene glycol; boric acid; mannitol; tyloxapol; sodium chloride; sodium hydroxide; purified water; carbomer 974p; hydrochloric acid; benzalkonium chloride - decrease of elevated intraocular pressure (iop) in adult patients with open-angle glaucoma or ocular hypertension for whom monotherapy provides insufficient iop reduction

DUO TRAV EYE DROPS Malasja - Ingliż - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

duo trav eye drops

novartis corporation (malaysia) sdn. bhd. - travoprost; timolol base -

VIZO-PF BIMATOPROST bimatoprost 300 microgram/mL eye drops bottle Awstralja - Ingliż - Department of Health (Therapeutic Goods Administration)

vizo-pf bimatoprost bimatoprost 300 microgram/ml eye drops bottle

aft pharmaceuticals pty ltd - bimatoprost, quantity: 300 microgram/ml - eye drops, solution - excipient ingredients: sodium chloride; citric acid monohydrate; hydrochloric acid; water for injections; dibasic sodium phosphate heptahydrate; sodium hydroxide - for the reduction of elevated intraocular pressure, or open angle glaucoma, as first line therapy or monotherapy or as adjunctive therapy to topical beta-blockers

VIZO-PF DORZOLATIM dorzolamide (as hydrochloride) 20 mg/mL and timolol (as maleate) 5 mg/mL eye drop solution multi-dose bottle Awstralja - Ingliż - Department of Health (Therapeutic Goods Administration)

vizo-pf dorzolatim dorzolamide (as hydrochloride) 20 mg/ml and timolol (as maleate) 5 mg/ml eye drop solution multi-dose bottle

aft pharmaceuticals pty ltd - dorzolamide hydrochloride, quantity: 22.26 mg/ml (equivalent: dorzolamide, qty 20 mg/ml); timolol maleate, quantity: 6.83 mg/ml (equivalent: timolol, qty 5 mg/ml) - eye drops, solution - excipient ingredients: sodium hydroxide; hyetellose; mannitol; water for injections; sodium citrate - vizo-pf dorzolatim is indicated in the treatment of elevated intraocular pressure (iop) in patients with ocular hypertension or open-angle glaucoma when concomitant therapy is appropriate.

Trusopt New Zealand - Ingliż - Medsafe (Medicines Safety Authority)

trusopt

mundipharma new zealand ltd - dorzolamide hydrochloride 2.226%{relative} equivalent to dorzolamide base 2% - eye drops, solution - 2 % - active: dorzolamide hydrochloride 2.226%{relative} equivalent to dorzolamide base 2% excipient: benzalkonium chloride hyetellose mannitol sodium citrate dihydrate sodium hydroxide water for injection - trusopt ophthalmic solution is indicated in the treatment of elevated intraocular pressure in patients with: · ocular hypertension · open-angle glaucoma · pseudoexfoliative glaucoma and other secondary open-angle glaucomas · in the short-term treatment of paediatric glaucomas as adjunctive therapy to beta-blockers and for monotherapy when other treatments have proved ineffective or are unsuitable.

BETOPTIC 0.5 Base %w/v Eye Drops Solution Irlanda - Ingliż - HPRA (Health Products Regulatory Authority)

betoptic 0.5 base %w/v eye drops solution

ltt pharma limited - betaxolol hydrochloride - eye drops solution - 0.5 base %w/v

TIMOPTOL 0.25 Base %w/v Eye Drops Solution Irlanda - Ingliż - HPRA (Health Products Regulatory Authority)

timoptol 0.25 base %w/v eye drops solution

merck sharp & dohme ireland (human health) limited - timolol maleate - eye drops solution - 0.25 base %w/v